Tirzepatide’s cardiovascular effects in clinical practice
-
By
-
Kathryn Wighton
-
August 28, 2026
-
4 min
By
Kathryn Wighton
August 28, 2026
Adults assigned to nonnutritive sweetened beverages or water maintained weight reductions through 104 weeks, with no statistically significant difference between groups.
October 6, 2026
Surveys captured nearly 7 times as many menopause observations as structured clinical records, with high agreement when both sources identified menopause.
September 14, 2026
Merck reported placebo-adjusted LDL-C reductions of 56% and 59% at week 24 in two phase 3 CORALreef trials supporting the approval.
July 16, 2026